Vericel (VCEL) FCF Margin Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Vericel | 1.69 Bn | 1.55 Bn | 49.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -661.00 |
| Dec 31, 2025 | -890.00 |
| Sep 30, 2025 | -1,517.00 |
| Jun 30, 2025 | 5,062.00 |
| Mar 31, 2025 | -2,935.00 |
| Dec 31, 2024 | -195.00 |
| Sep 30, 2024 | -6,876.00 |
| Jun 30, 2024 | 11,080.00 |
| Mar 31, 2024 | -1,293.00 |
| Dec 31, 2023 | -303.00 |
| Sep 30, 2023 | -547.00 |
| Jun 30, 2023 | 5,056.00 |
| Mar 31, 2023 | 1,237.00 |
| Dec 31, 2022 | 1,061.00 |
| Sep 30, 2022 | 3,286.00 |
| Jun 30, 2022 | 4,781.00 |
| Mar 31, 2022 | 3,443.00 |
| Dec 31, 2021 | 5,933.00 |
| Sep 30, 2021 | 5,038.00 |
| Jun 30, 2021 | 5,184.00 |
| Mar 31, 2021 | 3,741.00 |
| Dec 31, 2020 | 6,420.00 |
| Sep 30, 2020 | 1,375.00 |
| Jun 30, 2020 | 1,551.00 |
| Mar 31, 2020 | 5,279.00 |
| Dec 31, 2019 | 6,071.00 |
| Sep 30, 2019 | 11,056.00 |
| Jun 30, 2019 | 6,286.00 |
| Dec 31, 2018 | 5.43 Mn |
| Jun 30, 2018 | 15.74 Mn |
| Mar 31, 2018 | 8.47 Mn |
| Dec 31, 2017 | 3.92 Mn |
| Mar 31, 2017 | 33.42 Mn |
| Mar 31, 2016 | 7.30 Mn |